InsidersTradesSigma
Explore the full record of transactions filed by GORMAN KEVIN CHARLES. Officer active across 1 companies, notably Neurocrine Biosciences INC. Cumulatively, 2 disclosures have been logged. Total volume traded: €342k. The latest transaction was disclosed on 7 February 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations